National trends in radiation dose escalation for glioblastoma
Rodney E. Wegner, Stephen Abel, Zachary D. Horne, Shaakir Hasan, Vivek Verma, Tulika Ranjan, Richard W. Williamson, Stephen M. Karlovits
Radiat Oncol J. 2019;37(1):13-21. Published online 2019 Mar 31 DOI: https://doi.org/10.3857/roj.2019.00017
|
Citations to this article as recorded by
Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis
Sarah J Derby, Louise Dutton, Karen E Strathdee, Katrina Stevenson, Anna Koessinger, Mark Jackson, Yuling Tian, Wenxi Yu, Kathy Mclay, Josette Misquitta, Sama Alsharif, Cassie J Clarke, Lesley Gilmour, Peter Thomason, Ewan McGhee, Connor L McGarrity-Cottr
Neuro-Oncology.2024; 26(4): 625. CrossRef Dosimetric evaluation of adult and paediatric brain tumours planned using mask‐based cobalt‐60 fractionated stereotactic radiotherapy compared to linear accelerator‐based volumetric modulated arc therapy
Chin Heng Fong, Robert Heaton, Zhihui Amy Liu, Kecheng Li, Monique van Prooijen, Young‐Bin Cho, David B. Shultz, Derek S. Tsang
Journal of Medical Radiation Sciences.2023; 70(1): 64. CrossRef Shoot-through proton FLASH irradiation lowers linear energy transfer in organs at risk for neurological tumors and is robust against density variations
Esther Kneepkens, Cecile Wolfs, Roel-Germ Wanders, Erik Traneus, Danielle Eekers, Frank Verhaegen
Physics in Medicine & Biology.2023; 68(21): 215020. CrossRef PAK3 downregulation induces cognitive impairment following cranial irradiation
Haksoo Lee, Hyunkoo Kang, Changjong Moon, BuHyun Youn
eLife.2023;[Epub] CrossRef PAK3 downregulation induces cognitive impairment following cranial irradiation
Haksoo Lee, Hyunkoo Kang, Changjong Moon, BuHyun Youn
eLife.2023;[Epub] CrossRef Utility of Administrative Databases and Big Data on Understanding Glioma Treatment—A Systematic Review
Monica-Rae Owens, Sarah Nguyen, Michael Karsy
Indian Journal of Neurosurgery.2022; 11(02): 104. CrossRef Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
Ruijia Liang, Cheng Wu, Shiming Liu, Wenyan Zhao
Drug Delivery.2022; 29(1): 1620. CrossRef Targeting Glioma Stem Cells
Yagmur Muftuoglu, Frank Pajonk
Neurosurgery Clinics of North America.2021; 32(2): 283. CrossRef Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2)
Marica Ferro, Milena Ferro, Gabriella Macchia, Savino Cilla, Milly Buwenge, Alessia Re, Carmela Romano, Mariangela Boccardi, Vincenzo Picardi, Silvia Cammelli, Eleonora Cucci, Samantha Mignogna, Liberato Di Lullo, Vincenzo Valentini, Alessio Giuseppe Morg
Frontiers in Oncology.2021;[Epub] CrossRef Novel Treatment for Glioblastoma Delivered by a Radiation Responsive and Radiopaque Hydrogel
Mathilde Bouché, Yuxi C. Dong, Saad Sheikh, Kimberly Taing, Deeksha Saxena, Jessica C. Hsu, Minna H. Chen, Ryan D. Salinas, Hongjun Song, Jason A. Burdick, Jay Dorsey, David P. Cormode
ACS Biomaterials Science & Engineering.2021; 7(7): 3209. CrossRef Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost
Hsiang-Kuang Tony Liang, Masashi Mizumoto, Eiichi Ishikawa, Masahide Matsuda, Keiichi Tanaka, Hidehiro Kohzuki, Haruko Numajiri, Yoshiko Oshiro, Toshiyuki Okumura, Akira Matsumura, Hideyuki Sakurai
Journal of Cancer Research and Clinical Oncology.2021; 147(12): 3503. CrossRef FLASH Radiation Therapy: Review of the Literature and Considerations for Future Research and Proton Therapy FLASH Trials
Ronald Chow, Minglei Kang, Shouyi Wei, J.Isabelle Choi, Robert H. Press, Shaakir Hasan, Arpit M. Chhabra, Keith A. Cengel, Haibo Lin, Charles B. Simone
Applied Radiation Oncology.2021; : 16. CrossRef Improved 3-year survival rates for glioblastoma multiforme are associated with trends in treatment: analysis of the national cancer database from 2004 to 2013
Jad Zreik, F. M. Moinuddin, Yagiz U. Yolcu, Mohammed Ali Alvi, Kaisorn L. Chaichana, Alfredo Quinones-Hinojosa, Mohamad Bydon
Journal of Neuro-Oncology.2020; 148(1): 69. CrossRef Survival of glioblastoma treated with a moderately escalated radiation dose—Results of a retrospective analysis
Li-Tsun Shieh, How-Ran Guo, Chung-Han Ho, Li-Ching Lin, Chin-Hong Chang, Sheng-Yow Ho, Stephen Chun
PLOS ONE.2020; 15(5): e0233188. CrossRef Advances in drug delivery technology for the treatment of glioblastoma multiforme
Gi Doo Cha, Taegyu Kang, Seungmin Baik, Dokyoon Kim, Seung Hong Choi, Taeghwan Hyeon, Dae-Hyeong Kim
Journal of Controlled Release.2020; 328: 350. CrossRef Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis
Thomas J. Quinn, Muayad F. Almahariq, Zaid A. Siddiqui, Andrew B. Thompson, Daniel A. Hamstra, Peyman Kabolizadeh, Kate L. Gowans, Peter Y. Chen
Pediatric Blood & Cancer.2019;[Epub] CrossRef Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy
Danielle Cicka, Charles Lester Ford, Erica Templin, Zachary Pitts, Saumya Gurbani, Bree Eaton, Lindsey Lowder, Jeffrey Olson, Brent D Weinberg, Hyunsuk Shim, Soma Sengupta
Oxford Medical Case Reports.2019;[Epub] CrossRef Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
Wolfgang Wick, Andriy Krendyukov, Klaus Junge, Thomas Höger, Harald Fricke
Journal of Neuro-Oncology.2019; 145(3): 531. CrossRef
|